Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1982-12-16
|
pubmed:abstractText |
Noscapine was administered to five healthy volunteers in a randomized crossover design, as an intravenous infusion of 66 mg, and as an oral 150 mg dose of either rapidly dissolving tablets or a tablet containing ion exchange resin-bound noscapine. After i.v. administration, the disposition of noscapine was bi-exponential with an elimination half-life of 2.6 h; the total plasma clearance was 22 ml/min/kg and the volume of distribution (Vdarea) was 4.7 l/kg. The absolute oral bioavailability was 30%, with a 3.6-fold interindividual variation. There was no pharmacokinetic evidence to support a prolonged action of the ion exchange resin tablet.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0031-6970
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
22
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
535-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7128665-Administration, Oral,
pubmed-meshheading:7128665-Adult,
pubmed-meshheading:7128665-Biological Availability,
pubmed-meshheading:7128665-Female,
pubmed-meshheading:7128665-Humans,
pubmed-meshheading:7128665-Injections, Intravenous,
pubmed-meshheading:7128665-Intestinal Absorption,
pubmed-meshheading:7128665-Kinetics,
pubmed-meshheading:7128665-Male,
pubmed-meshheading:7128665-Noscapine,
pubmed-meshheading:7128665-Solubility
|
pubmed:year |
1982
|
pubmed:articleTitle |
Pharmacokinetic properties of noscapine.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|